Glass container products manufacturer O-I Glass’ (OI) shares have soared in price over the past month, and the company was also acknowledged for its sustainability initiatives. However, is it wise…
Author archives: Manisha Chatterjee
Here’s Why You Should Add Coty to Your Portfolio Now
Beauty company Coty (COTY) reported revenue growth across many of its categories in its last quarter. Also, the company expects its earnings to soar over the next few years. So,…
Is Senseonics a Winning Diabetes Stock to Own in 2022?
Diabetes-focused medical company Senseonics (SENS) reported top- and bottom-line growth in its last reported quarter. But is it wise to bet on the stock now despite the intense competition it…
Down Nearly 40% in the Past 3 Months, is Now a Good Time to Scoop Up Shares of Zoom Video Communications?
Despite the shares of Zoom Video Communications’ (ZM) having plunged nearly 40% in price over the past three months, the company has been making consistent product and services improvements. So,…
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
Israel-based Teva Pharmaceutical (TEVA) is conducting trials regarding the use of opioids. But is it wise to bet on the stock now based on its sound fundamentals? Read on, let’s…
Is Marqeta a Good Software Stock to Buy Now?
Software company Marqeta (MQ) has forged several strategic partnerships since going public on June 9, 2021. So, let’s evaluate if it is wise to buy the dip in the stock…
Should You Add Sirius XM Holdings Stock to Your Watchlist?
Audio company Sirius XM Holdings (SIRI) reported top-line and bottom-line growth in its last reported quarter. But can this stellar performance continue? Read on, let’s discuss.
Is General Motors a Good Stock to Own in 2022?
General Motors’ (GM) shares surged in price to hit their $67.21 all-time high on Jan. 5, 2022, after the company introduced its new EV at CES 2022. But is it…
Up More Than 480% in 2021, is Vertex Energy Still a Buy?
Environmental services company Vertex Energy’s (VTNR) shares have soared nearly 485% in price over the past year on investors’ optimism surrounding its proposed acquisition of an oil refinery. But can…
Is Biolase a Good Medical Device Stock to Add to Your Portfolio?
Dental-industry-focused medical device company BIOLASE (BIOL) recently received an extension from Nasdaq to meet the exchange’s minimum bid price requirement and reported revenue growth in the third quarter. However, is…